Physician profile
Ming T Wang
NPI 1265442636
$8,117.99
in general payments reported to CMS, 2019-2025
56 companies · $1,798 in 2025
The $1,798 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,116 · 2020: $126 · 2021: $108 · 2022: $940 · 2023: $1,516 · 2024: $2,514 · 2025: $1,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,727 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,727.43 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $790.84 | 2019-2025 | Botox, Ubrelvy |
| Lilly USA, LLC | $555.31 | 2019-2025 | Kisunla, Emgality, Reyvow |
| Supernus Pharmaceuticals, INC. | $453.18 | 2019-2024 | Qelbree |
| Genentech USA, INC. | $400.30 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Lundbeck LLC | $382.98 | 2019-2025 | Vyepti |
| Grifols USA, LLC | $361.26 | 2019-2025 | Gamunex-C |
| Biogen, INC. | $320.42 | 2019-2025 | Tysabri, Vumerity |
| Novartis Pharmaceuticals Corporation | $320.05 | 2019-2025 | |
| Catalyst Pharmaceuticals, INC. | $315.24 | 2022-2025 | Fycompa |
| Pfizer INC. | $306.32 | 2019-2025 | |
| Eisai INC. | $296.33 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $273.17 | 2019-2025 | Ultomiris, Soliris |
| Sk Life Science, INC. | $236.34 | 2020-2025 | |
| Ucb, INC. | $215.69 | 2019-2025 | Briviact, Zilbrysq, Fintepla |
| Neurocrine Biosciences, INC. | $205.66 | 2022-2025 | Ingrezza, Ongentys |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ming Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.